Inhibition of osteoblast differentiation by tumor necrosis factor-α

Endocrinology

Volumn 141, Issue 11, 2000, Pages 3956-3964

  Gilbert, L ^a   He, X ^a   Farmer, P ^a   Boden, S ^a   Kozlowski, M ^a   Rubin, J ^a   Nanes, M S ^a  

^a ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; DACTINOMYCIN; LIM PROTEIN; OSTEOCALCIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOSE RESPONSE; FETUS; MOUSE; NONHUMAN; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033695186     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.11.7739     Document Type: Article

References (55)

1. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
2. Cytokines, estrogen, and postmenopausal osteoporosis - The second decade
3. Recent advances in bone biology provide insight into the pathogenesis of bone diseases
4. Cytokines in the pathogenesis of osteoporosis
5. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency
6. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice
7. Effects of interferon-gamma and other cytokines on collagen synthesis in fetal rat bone cultures
8. Tumor necrosis factor-α inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures
9. Inhibitory effects of tumor necrosis factor-alpha and interferon-γ on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8)
10. 3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism
11. Effects of interleukin-1β and tumor necrosis factor-α on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro
12. Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human osteoblastic cells
13. Proinflammatory cytokines tumor necrosis factor-α and IL-6, but not IL-1, down-regulate the osteocalcin gene promoter
14. Actions of recombinant human gamma-interferon and tumor necrosis factor α on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro
15. The origin of bone cells
16. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations
17. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells
18. Advances in the osteoblast lineage
19. Mechanisms regulating osteoblast proliferation and differentiation
20. Synergistic effect of BMP-2 and ascorbate on the phenotypic expression of osteoblastic MC3T3-E1 cells
21. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication
22. Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures
23. Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats
24. The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts
25. The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone
26. LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation
27. Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6
28. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex
29. Osf2/Cbfa1:A transcriptional activator of osteoblast differentiation
30. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
31. Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines
32. Multiple extracellular signals promote osteoblast survival and apoptosis
33. Ceramide-induced nuclear translocation of NF-κB is a potential mediator of the apoptotic response to TNF-α in murine clonal osteoblasts
34. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone
35. Tumor necrosis factor-α and interleukin-1β increase the Fas-mediated apoptosis of human osteoblasts
36. Increased expression of tissue plasminogen activator messenger ribonucleic acid is an immediate response to parathyroid hormone in neonatal rat osteoblasts
37. Complexes of organic acids with calcium phosphate: The Von Kossa stain as a clue to the composition of bone mineral
38. 3H]thymidine incorporation assay
39. 3 stimulated osteocalcin gene transcription by tumor necrosis factor-α: Structural determinants within the vitamin D response element
40. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells
41. Phenotype suppression: A postulated molecular mechanism for mediating the relationship of proliferation and differentiation by Fos/Jun interactions at AP-1 sites in steroid responsive promoter elements of tissue-specific genes
42. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential
43. Effect of tumor necrosis factor-α on the expression of insulin-like growth factor I and insulin-like growth factor binding protein 4 in mouse osteoblasts
44. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix
45. Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting element in the mouse osteocalcin promoters
46. Transcription factors and osteoblasts
47. TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARγ without effects on Pref-1 expression
48. Tumor necrosis factor-α prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells
49. Regulation of collagen gene expression in 3T3-L1 cells. Effects of adipocyte differentiation and tumor necrosis factor α
50. Osteoporosis in rheumatoid arthritis: A molecular biological aspect of connective tissue gene activation
51. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD
52. Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice
53. Expression of interleukin-1β and tumour necrosis factor-α in plasma cells from patients with multiple myeloma
54. TNF-α increases expression of IL-6 and ICAM-1 genes through activation of NF-κB in osteoblast-like ROS17/2.8 cells
55. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ